These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3804497)

  • 21. Tumor necrosis factor-alpha augmented tumor response in B16BL6 melanoma-bearing mice treated with stealth liposomal doxorubicin (Doxil) correlates with altered Doxil pharmacokinetics.
    Brouckaert P; Takahashi N; van Tiel ST; Hostens J; Eggermont AM; Seynhaeve AL; Fiers W; ten Hagen TL
    Int J Cancer; 2004 Apr; 109(3):442-8. PubMed ID: 14961585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Damaging action of human recombinant TNF on tumor vessels as an aspect of its anti-neoplastic action against Meth A sarcoma in mice].
    Nakamura H; Motoyoshi S; Seto Y; Kadokawa T; Nakata K; Iida M; Taguchi T
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):91-9. PubMed ID: 3800409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor activity of recombinant human tumor necrosis factor in combination with hyperthermia, chemotherapy, or immunotherapy.
    Haranaka K; Sakurai A; Satomi N
    J Biol Response Mod; 1987 Aug; 6(4):379-91. PubMed ID: 3625230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of tolerance on antitumor efficacy of tumor necrosis factor in mice.
    Fraker DL; Sheppard BC; Norton JA
    Cancer Res; 1990 Apr; 50(8):2261-7. PubMed ID: 2317813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of tumor necrosis factor (TNF) on transplanted tumors induced by methylcholanthrene in mice. A histopathologic study.
    Kawai T; Satomi N; Sato N; Sakurai A; Haranaka K; Goto T; Suzuki M
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 52(6):489-500. PubMed ID: 2884771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular targeting agents enhance chemotherapeutic agent activities in solid tumor therapy.
    Siemann DW; Mercer E; Lepler S; Rojiani AM
    Int J Cancer; 2002 May; 99(1):1-6. PubMed ID: 11948484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Increased anti-tumor activity of chemotherapeutic agents combined with direct current against murine transplanted tumors].
    Ito H; Nakayama T; Shigematsu N; Nishiguchi I; Hashimoto S
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1854-9. PubMed ID: 3496048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic antitumour effect of TNF-SAM2 with melphalan and doxorubicin in isolated limb perfusion in rats.
    de Wilt JH; Soma G; ten Hagen TL; Kanou J; Takagi K; Nooijen PT; Seynhaevel AL; Eggermont AM
    Anticancer Res; 2000; 20(5B):3491-6. PubMed ID: 11131652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients' colon tumors grown in SCID mice.
    Naka T; Sugamura K; Hylander BL; Widmer MB; Rustum YM; Repasky EA
    Cancer Res; 2002 Oct; 62(20):5800-6. PubMed ID: 12384541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic effects of TNF-alpha and melphalan in an isolated limb perfusion model of rat sarcoma: a histopathological, immunohistochemical and electron microscopical study.
    Nooijen PT; Manusama ER; Eggermont AM; Schalkwijk L; Stavast J; Marquet RL; de Waal RM; Ruiter DJ
    Br J Cancer; 1996 Dec; 74(12):1908-15. PubMed ID: 8980389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenic chemotherapy with cyclophosphamide and doxorubicin against established murine carcinoma.
    Tongu M; Harashima N; Yamada T; Harada T; Harada M
    Cancer Immunol Immunother; 2010 May; 59(5):769-77. PubMed ID: 19940990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antitumor activity of tumor necrosis factor (TNF) in vitro and in vivo].
    Haranaka K; Satomi N; Sakurai A
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1387-93. PubMed ID: 6742865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levels of viral glycoprotein reflect enhanced effectiveness of combined drug treatments.
    Ritzi EM; Pyo S
    Life Sci; 1994; 54(13):887-99. PubMed ID: 8139377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal scheduling of interleukin 12 and chemotherapy in the murine MB-49 bladder carcinoma and B16 melanoma.
    Teicher BA; Ara G; Buxton D; Leonard J; Schaub RG
    Clin Cancer Res; 1997 Sep; 3(9):1661-7. PubMed ID: 9815857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Necrotizing activity of tumor necrosis factor: histopathological investigation using Meth A sarcoma and granulation tissue.
    Kawai T; Satomi N; Sato N; Sakurai A; Haranaka K; Goto T; Suzuki M
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 53(6):353-8. PubMed ID: 2891219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potentiation of combination chemotherapy by nitroheterocyclics.
    Siemann DW; Allalunis-Turner MJ
    Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):129-34. PubMed ID: 3391809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-tumor effect of tumor necrosis factor combined with electrotherapy on mouse sarcoma.
    Sersa G; Golouh R; Miklavcic D
    Anticancer Drugs; 1994 Feb; 5(1):69-74. PubMed ID: 8186433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-Methylformamide (NSC 3051): a potential candidate for combination chemotherapy.
    Langdon SP; Hickman JA; Gescher A; Stevens MF; Chubb D; Vickers LM
    Eur J Cancer Clin Oncol; 1985 Jun; 21(6):745-52. PubMed ID: 4018116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor necrosis factor as an adjunct to fractionated radiotherapy in the treatment of murine tumors.
    Nishiguchi I; Willingham V; Milas L
    Int J Radiat Oncol Biol Phys; 1990 Mar; 18(3):555-8. PubMed ID: 2318687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type.
    Behr TM; Wulst E; Radetzky S; Blumenthal RD; Dunn RM; Gratz S; Rave-Fränk M; Schmidberger H; Raue F; Becker W
    Cancer Res; 1997 Dec; 57(23):5309-19. PubMed ID: 9393755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.